Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Anton Reepalu"'
Publikováno v:
Global Health Action, Vol 17, Iss 1 (2024)
Introduction Although antiretroviral therapy (ART) leads to reduced tuberculosis (TB) incidence in people with HIV (PWH), ART recipients remain at higher risk of TB compared to HIV-seronegative people. With accelerated ART rollout in sub-Saharan Afri
Externí odkaz:
https://doaj.org/article/cbcd1dbf11a54095b44274ba3fb5b7b3
Autor:
Johannes Thorman, Per Björkman, Gaetano Marrone, Taye Tolera Balcha, Fregenet Tesfaye, Tamene Abdissa, Denise Naniche, Patrik Medstrand, Anton Reepalu
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 3 (2021)
ABSTRACT Interferon-γ-inducible protein 10 (IP-10) has been suggested as a marker for targeted viral load (VL) monitoring during antiretroviral treatment (ART). We aimed to determine the kinetics of IP-10 during the initial year of ART, with particu
Externí odkaz:
https://doaj.org/article/18242ed626e140b888557b10ebc5fc10
Autor:
Per Swärd, Andreas Edsfeldt, Anton Reepalu, Lars Jehpsson, Björn E. Rosengren, Magnus K. Karlsson
Publikováno v:
Critical Care, Vol 24, Iss 1, Pp 1-3 (2020)
Externí odkaz:
https://doaj.org/article/5eae11f1f760454f8a21833f30d53370
Publikováno v:
Global Health Action, Vol 9, Iss 0, Pp 1-8 (2016)
Background: Access to second-line antiretroviral therapy (ART) for HIV-positive patients remains limited in sub-Saharan Africa. Furthermore, outcomes of second-line ART may be compromised by mortality and loss to follow-up (LTFU). Objective: To deter
Externí odkaz:
https://doaj.org/article/6871772dc8604c40b576ce4a43525fb1
Autor:
Anton Reepalu, Taye Tolera Balcha, Sten Skogmar, Per-Erik Isberg, Patrik Medstrand, Per Björkman
Publikováno v:
Global Health Action, Vol 10, Iss 1 (2017)
Background: Early identification of virological failure (VF) limits occurrence and spread of drug-resistant viruses in patients receiving antiretroviral treatment (ART). Viral load (VL) monitoring is therefore recommended, but capacities to comply wi
Externí odkaz:
https://doaj.org/article/2ae32d3eb6464dd3bd8c97d8d5878bf7
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156602 (2016)
INTRODUCTION:Despite increasing access to antiretroviral treatment (ART) in low-income countries, HIV-related mortality is high, especially in the first months following ART initiation. We aimed to evaluate the impact of TB coinfection on early morta
Externí odkaz:
https://doaj.org/article/5f128c71b5bc46d59190f368831f4842
Autor:
Taye T Balcha, Erik Sturegård, Niclas Winqvist, Sten Skogmar, Anton Reepalu, Zelalem Habtamu Jemal, Gudeta Tibesso, Thomas Schön, Per Björkman
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85478 (2014)
Detection of active tuberculosis (TB) before antiretroviral therapy (ART) initiation is important, but optimal diagnostic methods for use in resource-limited settings are lacking. We assessed the prevalence of TB, evaluated the diagnostic yield of Xp
Externí odkaz:
https://doaj.org/article/8ffb582099804a269e69d0d4d9033582
Autor:
Ingrid Didriksson, Märta Leffler, Martin Spångfors, Sarah Lindberg, Anton Reepalu, Anna Nilsson, Jonas Cronqvist, Sara Andertun, Maria Nelderup, Mårten Jungner, Patrik Johnsson, Gisela Lilja, Attila Frigyesi, Hans Friberg
Publikováno v:
Acta Anaesthesiologica Scandinavica. 67:329-338
Traditional models to predict intensive care outcomes do not perform well in COVID-19. We undertook a comprehensive study of factors affecting mortality and functional outcome after severe COVID-19.In this prospective multicentre cohort study, we enr
Autor:
Johannes Thorman, Per Björkman, Sviataslau Sasinovich, Fregenet Tesfaye, Daba Mulleta, Patrik Medstrand, Anton Reepalu
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes.
Autor:
Asiya Jeylan, Anton Reepalu, Taye Tolera Balcha, Per Björkman, Johannes Thorman, Fregenet Tesfaye
Publikováno v:
Tropical Medicine & International Health. 24:356-362
Restricted capacity for viral load (VL) testing is a major obstacle for antiretroviral therapy (ART) programmes in high-burden regions. Algorithms for targeted VL testing could help allocate laboratory resources rationally. We validated the performan